Skip to main content
Top
Published in: Cardiovascular Ultrasound 1/2009

Open Access 01-12-2009 | Research

Hypercholesterolemia and Myocardial function evaluated via Tissue Doppler Imaging

Authors: Jack Rubinstein, Augusta Pelosi, Ameeth Vedre, Pavan Kotaru, George S Abela

Published in: Cardiovascular Ultrasound | Issue 1/2009

Login to get access

Abstract

Objective

To establish a link between hypercholesterolemia and myocardial dysfunction.

Background

Heart failure is a complex disease involving changes in systolic and diastolic function. Newer echocardiographic imaging modalities may be able to detect discreet changes in myocardial function associated with hypercholesterolemia. Therefore we sought to establish a link between hypercholesterolemia and myocardial dysfunction with tissue Doppler imaging (TDI).

Methods

Twenty-seven rabbits were studied: 7 were fed normal chow (group 1) and 20 a high cholesterol diet (10 with ezetimibe, 1 mg/kg/day; group 2 and 10 without, group 3). Echocardiographic images were obtained under general anesthesia. Serum cholesterol levels were obtained at baseline, 3 and 6 months and myocardial cholesterol levels measured following euthanasia.

Results

Doppler measurements, including E/A, E'/A' and S' were significantly lower in group 3 compared to both groups 1 and 2 but no significant differences were noted in chamber sizes or ejection fraction among the groups. Average serum cholesterol was higher in group 3 compared to groups 1 and 2 respectively (495 ± 305 mg/dl vs. 114 ± 95 mg/dl and 87 ± 37 mg/dl; p < 0.01). Myocardial cholesterol content was also higher in group 3 compared to group 2 (0.10 ± 0.04 vs. 0.06 mg/dl ± 0.02; p = 0.05). There was significant correlation between S', E'/A', E/E' and serum cholesterol (r2 = 0.17 p = 0.04, r2 = 0.37 p = 0.001 and r2 = 0.24 p = 0.01).

Conclusion

Cholesterol load in the serum and myocardium was significantly associated with decreased systolic and diastolic function by TDI. Moreover, lipid lowering was protective.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y: Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115: e69-171.CrossRefPubMed Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y: Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115: e69-171.CrossRefPubMed
3.
go back to reference Castelli WP, Anderson K, Wilson PW, Levy D: Lipids and risk of coronary heart disease. The Framingham Study. Annals of Epidemiology 2: 23-8. Castelli WP, Anderson K, Wilson PW, Levy D: Lipids and risk of coronary heart disease. The Framingham Study. Annals of Epidemiology 2: 23-8.
4.
go back to reference Stokes KY, Cooper D, Tailor A, Granger DN: Hypercholesterolemia promotes inflammation and microvascular dysfunction: Role of nitric oxide and superoxide. Free Radical Biology & Medicine 2002, 33: 1026-1036.CrossRef Stokes KY, Cooper D, Tailor A, Granger DN: Hypercholesterolemia promotes inflammation and microvascular dysfunction: Role of nitric oxide and superoxide. Free Radical Biology & Medicine 2002, 33: 1026-1036.CrossRef
5.
go back to reference Simes J, Furberg CD, Braunwald E, Davis BR, Ford I, Tonkin A, Shepherd J: Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project. Eur Heart J 2002, 23: 207-15.CrossRefPubMed Simes J, Furberg CD, Braunwald E, Davis BR, Ford I, Tonkin A, Shepherd J: Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project. Eur Heart J 2002, 23: 207-15.CrossRefPubMed
6.
go back to reference Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC: Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004, 43: 1439-44.CrossRefPubMed Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC: Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004, 43: 1439-44.CrossRefPubMed
7.
go back to reference GISSI-HF investigators: Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372: 1231-9.CrossRef GISSI-HF investigators: Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372: 1231-9.CrossRef
8.
go back to reference Lavie CJ, Mehra MR, Milani RV: Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J 2005, 26: 5-7.CrossRefPubMed Lavie CJ, Mehra MR, Milani RV: Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J 2005, 26: 5-7.CrossRefPubMed
9.
go back to reference Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112: e154-235.CrossRefPubMed Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112: e154-235.CrossRefPubMed
10.
go back to reference Yu C-M, Sanderson JE, Marwick TH, Oh JK: Tissue Doppler imaging a new prognosticator for cardiovascular diseases. J Am Coll Cardiol 2007, 49: 1903-14.CrossRefPubMed Yu C-M, Sanderson JE, Marwick TH, Oh JK: Tissue Doppler imaging a new prognosticator for cardiovascular diseases. J Am Coll Cardiol 2007, 49: 1903-14.CrossRefPubMed
11.
go back to reference Dokainish H, Zoghbi WA, Lakkis NM, Ambriz E, Patel R, Quinones MA, Nagueh SF: Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 2005, 45: 1223-6.CrossRefPubMed Dokainish H, Zoghbi WA, Lakkis NM, Ambriz E, Patel R, Quinones MA, Nagueh SF: Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 2005, 45: 1223-6.CrossRefPubMed
12.
go back to reference Wang M, Yip GWK, Yu CM, Zhang Y, Zhang Q, Tse MK, Kong SL, Sanderson JE: Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function. J Am Coll Cardiol 2005, 45: 272-7.CrossRefPubMed Wang M, Yip GWK, Yu CM, Zhang Y, Zhang Q, Tse MK, Kong SL, Sanderson JE: Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function. J Am Coll Cardiol 2005, 45: 272-7.CrossRefPubMed
14.
go back to reference Abela GS, Picon PD, Friedl SE, Gebara OC, Miyamoto A, Federman M, Tofler GH, Muller JE: Triggering of Plaque Disruption and Arterial Thrombosis in an Atherosclerotic Rabbit Model. Circulation 1995, 91: 776-84.CrossRefPubMed Abela GS, Picon PD, Friedl SE, Gebara OC, Miyamoto A, Federman M, Tofler GH, Muller JE: Triggering of Plaque Disruption and Arterial Thrombosis in an Atherosclerotic Rabbit Model. Circulation 1995, 91: 776-84.CrossRefPubMed
15.
go back to reference Yanni AE: The laboratory rabbit: an animal model of atherosclerosis research. Laboratory animals 2004, 38: 246-56.CrossRefPubMed Yanni AE: The laboratory rabbit: an animal model of atherosclerosis research. Laboratory animals 2004, 38: 246-56.CrossRefPubMed
16.
go back to reference Nagueh SF, Kopelen HA, Lim DS, Zoghbi WA, Quinones MA, Roberts R, Marian AJ: Tissue Doppler Imaging Consistently Detects Myocardial Contraction and Relaxation Abnormalities, Irrespective of Cardiac Hypertrophy, in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy. Circulation 2000, 102: 1346-50.CrossRefPubMedPubMedCentral Nagueh SF, Kopelen HA, Lim DS, Zoghbi WA, Quinones MA, Roberts R, Marian AJ: Tissue Doppler Imaging Consistently Detects Myocardial Contraction and Relaxation Abnormalities, Irrespective of Cardiac Hypertrophy, in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy. Circulation 2000, 102: 1346-50.CrossRefPubMedPubMedCentral
17.
go back to reference Fontes-Sousa APN, Bras-Silva C, Moura C, Areias JC, Leite-Moreira AF: M-mode and Doppler echocardiographic reference values for male New Zealand white rabbits. Am J Vet Res 2006, 67: 1725-9.CrossRefPubMed Fontes-Sousa APN, Bras-Silva C, Moura C, Areias JC, Leite-Moreira AF: M-mode and Doppler echocardiographic reference values for male New Zealand white rabbits. Am J Vet Res 2006, 67: 1725-9.CrossRefPubMed
18.
go back to reference Vuille C, Weyman AE: Left ventricle I: general considerations, assessment of chamber size and function. In Principles and Practice of Echocardiography. 2nd edition. Edited by: Vuille C, Weyman AE. Philadelphia, PA, USA: Lea & Febiger; 1994:575-611. Vuille C, Weyman AE: Left ventricle I: general considerations, assessment of chamber size and function. In Principles and Practice of Echocardiography. 2nd edition. Edited by: Vuille C, Weyman AE. Philadelphia, PA, USA: Lea & Febiger; 1994:575-611.
19.
go back to reference Huang Y, Walker KE, Hanley F, Narula J, Houser SR, Tulenko TN: Cardiac Systolic and Diastolic Dysfunction After a Cholesterol-Rich Diet. Circulation 2004, 109: 97-102.CrossRefPubMed Huang Y, Walker KE, Hanley F, Narula J, Houser SR, Tulenko TN: Cardiac Systolic and Diastolic Dysfunction After a Cholesterol-Rich Diet. Circulation 2004, 109: 97-102.CrossRefPubMed
20.
go back to reference Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ, Yamada KA, Brunet S, Xu H, Nerbonne JM, Welch MJ, Fettig NM, Sharp TL, Sambandam N, Olson KM, Ory DS, Schaffer JE: Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res 2005, 96: 225-33.CrossRefPubMed Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ, Yamada KA, Brunet S, Xu H, Nerbonne JM, Welch MJ, Fettig NM, Sharp TL, Sambandam N, Olson KM, Ory DS, Schaffer JE: Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res 2005, 96: 225-33.CrossRefPubMed
21.
go back to reference McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, Levine BD, Raskin P, Victor RG, Szczepaniak LS: Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 2007, 116: 1170-5.CrossRefPubMed McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, Levine BD, Raskin P, Victor RG, Szczepaniak LS: Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 2007, 116: 1170-5.CrossRefPubMed
22.
go back to reference Zaca V, Rastogi S, Imai M, Wang M, Sharov VG, Jiang A, Goldstein S, Sabbah HN: Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure. J Am Coll Cardiol 2007, 50: 551-7.CrossRefPubMed Zaca V, Rastogi S, Imai M, Wang M, Sharov VG, Jiang A, Goldstein S, Sabbah HN: Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure. J Am Coll Cardiol 2007, 50: 551-7.CrossRefPubMed
23.
go back to reference Wu J-H, Hagaman J, Kim S, Reddick RL, Maeda N: Aortic constriction exacerbates atherosclerosis and induces cardiac dysfunction in mice lacking apolipoprotein E. Arterioscler Thromb Vasc Biol 2002, 22: 469-75.CrossRefPubMed Wu J-H, Hagaman J, Kim S, Reddick RL, Maeda N: Aortic constriction exacerbates atherosclerosis and induces cardiac dysfunction in mice lacking apolipoprotein E. Arterioscler Thromb Vasc Biol 2002, 22: 469-75.CrossRefPubMed
24.
25.
go back to reference Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JGF, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Jánosi A, Kamensk G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJV, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J, for the CORONA Group: Rosuvastatin in Older Patients with Systolic Heart Failure. N Engl J Med 2007, 357: 2248-61.CrossRefPubMed Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JGF, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Jánosi A, Kamensk G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJV, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J, for the CORONA Group: Rosuvastatin in Older Patients with Systolic Heart Failure. N Engl J Med 2007, 357: 2248-61.CrossRefPubMed
26.
go back to reference Kjekshus J, Pedersen TR, Olsson AG, Faergeman O, Pyörälä K: The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. J Card Fail 1997, 3: 249-54.CrossRefPubMed Kjekshus J, Pedersen TR, Olsson AG, Faergeman O, Pyörälä K: The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. J Card Fail 1997, 3: 249-54.CrossRefPubMed
27.
go back to reference de Lorgeril M, Salen P, Bontemps L, Belichard P, Geyssant A, Itti R: Effects of lipid-lowering drugs on left ventricular function and exercise tolerance in dyslipidemic coronary patients. J Cardiovasc Pharmacol 1999, 33: 473-8.CrossRefPubMed de Lorgeril M, Salen P, Bontemps L, Belichard P, Geyssant A, Itti R: Effects of lipid-lowering drugs on left ventricular function and exercise tolerance in dyslipidemic coronary patients. J Cardiovasc Pharmacol 1999, 33: 473-8.CrossRefPubMed
28.
go back to reference Dickinson MG, Ip JH, Olshansky B, Hellkamp AS, Anderson J, Poole JE, Mark DB, Lee KL, Bardy GH: Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 2007, 153: 573-8.CrossRefPubMed Dickinson MG, Ip JH, Olshansky B, Hellkamp AS, Anderson J, Poole JE, Mark DB, Lee KL, Bardy GH: Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 2007, 153: 573-8.CrossRefPubMed
29.
go back to reference Van Heek M, France CF, Compton DS, Mcleod RL, Yumibe NP, Alton KB, Sybertz EJ, Davis HR Jr: In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH5 in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. J Pharmacol Exp Ther 8235, 283: 157-63. Van Heek M, France CF, Compton DS, Mcleod RL, Yumibe NP, Alton KB, Sybertz EJ, Davis HR Jr: In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH5 in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. J Pharmacol Exp Ther 8235, 283: 157-63.
30.
go back to reference Masoudi FA, Inzucchi SE: Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy. Am J Cardiol 2007, 99: 113B-132B.CrossRefPubMed Masoudi FA, Inzucchi SE: Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy. Am J Cardiol 2007, 99: 113B-132B.CrossRefPubMed
31.
go back to reference Dabestani A, Child JS, Peloff JK, Figueroa WG, Schelbert HR, Engel TR: Cardiac abnormalities in primary hemochromatosis. Ann N Y Acad Sci 1988, 526: 234-44.CrossRefPubMed Dabestani A, Child JS, Peloff JK, Figueroa WG, Schelbert HR, Engel TR: Cardiac abnormalities in primary hemochromatosis. Ann N Y Acad Sci 1988, 526: 234-44.CrossRefPubMed
32.
go back to reference Ashrafian H, Frenneaux MP, Opie LH: Metabolic Mechanisms in Heart Failure. Circulation 2007, 116: 434-48.CrossRefPubMed Ashrafian H, Frenneaux MP, Opie LH: Metabolic Mechanisms in Heart Failure. Circulation 2007, 116: 434-48.CrossRefPubMed
33.
go back to reference O'Keefe JH, Gheewala NM, O'Keefe JO: Dietary Strategies for Improving Post-Prandial Glucose, Lipids, Inflammation, and Cardiovascular Health. J Am Coll Cardiol 2008, 51: 249-55.CrossRefPubMed O'Keefe JH, Gheewala NM, O'Keefe JO: Dietary Strategies for Improving Post-Prandial Glucose, Lipids, Inflammation, and Cardiovascular Health. J Am Coll Cardiol 2008, 51: 249-55.CrossRefPubMed
34.
go back to reference Poornima IG, Parikh P, Shannon RP: Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 2006, 98: 596-605.CrossRefPubMed Poornima IG, Parikh P, Shannon RP: Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 2006, 98: 596-605.CrossRefPubMed
35.
go back to reference Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, Noon GP, Frazier OH, Taegtmeyer H: Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 2004, 18: 1692-1700.CrossRefPubMed Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, Noon GP, Frazier OH, Taegtmeyer H: Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 2004, 18: 1692-1700.CrossRefPubMed
Metadata
Title
Hypercholesterolemia and Myocardial function evaluated via Tissue Doppler Imaging
Authors
Jack Rubinstein
Augusta Pelosi
Ameeth Vedre
Pavan Kotaru
George S Abela
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Cardiovascular Ultrasound / Issue 1/2009
Electronic ISSN: 1476-7120
DOI
https://doi.org/10.1186/1476-7120-7-56

Other articles of this Issue 1/2009

Cardiovascular Ultrasound 1/2009 Go to the issue